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The method of optimization includes: i) cell type; ii) source of dexamethasone; 
and iii) percentage of oxygen. In the experiment three different cell culture types 
were used: chondrocytes, human mesenchymal stem cells from bone marrow 
(hMSC) and combination of chondrocytes and hMSC in 2:1 ratio. Cells were grown 
in 3D culture, incorporated in a peptide hydrogel RADA (BD PuraMatrix Peptide 
Hydrogel). In order to induce chondrogenesis, cells were put in a differentiation me-
dium containing ascorbic acid-2-phosphate, L-proline, ITS, TGFβ-1 and dexametha-
sone. Dexamethasone was added in a differentiation medium or it was incorporated 
with cells within a peptide hydrogel. In order to demonstrate the effect of oxygen 
level on the efficiency of chondrogenic differentiation, cells were grown in normoxic 
(20% O2) and hypoxic conditions (5%O2). Expression levels of two important car-
tilage marker genes, SOX9 and agreccan, were evaluated by quantitative PCR in 
samples on day10 and day21 after induction of chondrogenesis. 
Our results provide important insights into effects of how different cell type, 
dexamethasone source and oxygen level affect efficiency of in vitro chondrogenesis. 
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Platelet-rich plasma (PRP) due to its role in wound healing, has spanned various 
fields of orthopaedics and sports medicine . Among athletes muscle injuries are com-
mon and may be associated with impaired functional capacity. The vulnerability of 
athletes to strains and contusions represents a substantial problem for professional 
players and their clubs. Such injuries involve significant time lost from training and 
competition. Presently there are no drugs available to hasten restoration of muscle 
function after injury and the results of healing with conventional therapy including 
rest, ice, compression, and elevation (RICE) are often inadequate. Therefore platelet-
rich plasma (PRP) therapies may help athletes by promoting muscle regeneration , 
enhancing the process of soft-tissue healing and to decrease time to recovery.PRP 
is generally considered an elective treatment for subacute and chronic conditions. 
In orthopaedics and sports medicine is used to treat tendinopathies, ligament spra-
ins, muscle strains, degenerative joint conditions. PRP is obtained from a sample 
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of patients blood drawn at the time of treatment,and it is prepared in a process of 
differential centrifugation,where acceleration force is adjusted to sediment certain 
cellular constituents based on different specific gravity. Suspensions have different 
concentration of platelets and leucocytes depending on the method and time of its 
centrifugation.PRP injections may be performed unaided or under ultrasound gui-
dance. Multiple injection techniques have been employed including intramuscular 
delivery of a singular bolus, multiple depots at the site of maximal injury, or a single 
injection into the muscle insertion site. 
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We have previously shown that tendon perivascular cells (TPCs) express mar-
kers associated with tendon cells and neural stem cells, such as Nestin and Musas-
hi1. Findings that tendon cells express a variety of neuron associated markers such 
as acetylcholine, M2 acetylcholine receptors or substance P now lead us to hypothe-
size that tendons harbour a cell population of neural crest origin. 
By immunohistochemistry using antibodies specific for tendon, neural crest 
and neuron associated markers on control- and Rosa26-YFP-Sox10-Cre mice as well 
as on Scleraxis-GFP mice and by in vitro differentiation assays on cultured murine 
tendon cells we characterized tendon cell in vitro and in vivo. 
Murine Achilles tendon cells coexpress p75NTR, Tenomodulin, Doublecortin, 
Neurofilament and TUJ1. 
Tendon cells from sox10cre mice express YFP together with tenomodulin the 
tail tendon anlagen of of E13.5 embryos. YFP is detectable in the Achilles tendons of 
adult animals. Tendon cells in tails of Scleraxis-GFP e13.5 embryos partly co-express 
p75 and GFP. 
In vitro murine tendon cells differentiate into functional neurons with the capa-
city to generate spontaneous action potentials, detected by multi electrode array. 
With this work we show that murine tendon cells express a variety of neuron 
associated markers. Analysis of Rosa26-YFP-Sox10-Cre and Scleraxis- GFP mouse 
tendons reveals a potential neural crest origin of a tendon cell population. 
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